A Phase I/II Clinical Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 18 Jul 2017
At a glance
- Drugs Napabucasin (Primary) ; Cisplatin; Pemetrexed
- Indications Mesothelioma; Non-small cell lung cancer
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Sumitomo Dainippon Pharma
- 13 Jul 2017 Planned primary completion date changed from 1 May 2017 to 1 Nov 2017.
- 19 Jul 2016 Planned primary completion date changed from 1 May 2016 to 1 May 2017.
- 19 Jul 2016 Status changed from recruiting to active, no longer recruiting.